Home › Compare › RIBS vs MRK

RIBS vs MRK: Dividend Comparison 2026

RIBS yields 1000000.00% · MRK yields 3.25%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 RIBS wins by $4.7683925249533696e+36M in total portfolio value
10 years
RIBS
RIBS
● Live price
1000000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.7683925249533696e+36M
Annual income
$4,767,454,694,456,067,000,000,000,000,000,000,000,000,000.00
Full RIBS calculator →
MRK
Merck & Co. Inc.
● Live price
3.25%
Share price
$94.80
Annual div
$3.08
5Y div CAGR
8.2%
Payout ratio
42%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.7K
Annual income
$950.29
Full MRK calculator →

Portfolio growth — RIBS vs MRK

📍 RIBS pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRIBSMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RIBS + MRK cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
RIBS pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RIBS
Annual income on $10K today (after 15% tax)
$85,000,000.00/yr
After 10yr DRIP, annual income (after tax)
$4,052,336,490,287,657,000,000,000,000,000,000,000,000,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$276.16/yr
After 10yr DRIP, annual income (after tax)
$807.75/yr
At 15% tax rate, RIBS beats the other by $4,052,336,490,287,657,000,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RIBS + MRK for your $10,000?

RIBS: 50%MRK: 50%
100% MRK50/50100% RIBS
Portfolio after 10yr
$2.3841962624766848e+36M
Annual income
$2,383,727,347,228,033,600,000,000,000,000,000,000,000,000.00/yr
Blended yield
99.98%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

RIBS
No analyst data
Altman Z
0.0
Piotroski
2/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+35.6% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RIBS buys
0
MRK buys
0
No recent congressional trades found for RIBS or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRIBSMRK
Forward yield1000000.00% ✓3.25%
Annual dividend / share$2.00$3.08 ✓
Payout ratio50%42% ✓
1-year div growth0%5.5% ✓
5-year div CAGR0%8.2% ✓
Portfolio after 10y$4.7683925249533696e+36M$30.7K ✓
Annual income after 10y$4,767,454,694,456,067,000,000,000,000,000,000,000,000,000.00 ✓$950.29
Total dividends collected$4.7683311610149396e+36M$6.1K ✓
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: RIBS vs MRK ($10,000, DRIP)

YearRIBS PortfolioRIBS Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$100,010,700$100,000,000.00$11,192$351.54+$100.00M → RIBS
2$934,786,450,701$934,679,439,252.34$12,524$392.70+$934786.44M → RIBS
3$8,165,787,108,578,292$8,164,786,887,076,042.00$14,015$438.65+$8165787108.56M → RIBS
4$66,665,884,190,957,650,000$66,657,146,798,751,470,000.00$15,682$489.96+$66665884190957.63M → RIBS
5$508,662,171,058,048,100,000,000$508,590,838,561,963,700,000,000.00$17,547$547.23+$508662171058048128.00M → RIBS
6$3,627,235,248,428,489,700,000,000,000$3,626,690,979,905,457,600,000,000,000.00$19,632$611.16+$3.62723524842849e+21M → RIBS
7$24,173,681,159,150,610,000,000,000,000,000$24,169,800,017,434,790,000,000,000,000,000.00$21,963$682.53+$2.417368115915061e+25M → RIBS
8$150,567,402,861,454,640,000,000,000,000,000,000$150,541,537,022,614,370,000,000,000,000,000,000.00$24,571$762.18+$1.5056740286145463e+29M → RIBS
9$876,477,100,281,847,600,000,000,000,000,000,000,000$876,315,993,160,785,800,000,000,000,000,000,000,000.00$27,486$851.08+$8.764771002818475e+32M → RIBS
10$4,768,392,524,953,369,600,000,000,000,000,000,000,000,000$4,767,454,694,456,067,000,000,000,000,000,000,000,000,000.00$30,745$950.29+$4.7683925249533696e+36M → RIBS

RIBS vs MRK: Complete Analysis 2026

RIBS — Stock

Southern Concepts Restaurant Group, Inc. does not have significant business operations. Previously, it owned and managed restaurants in Colorado. The company was formerly known as Bourbon Brothers Holding Corporation and changed its name to Southern Concepts Restaurant Group, Inc. in March 2015. Southern Concepts Restaurant Group, Inc. was founded in 2008 and is headquartered in Colorado Springs, Colorado.

Full RIBS Calculator →

MRK — Healthcare

Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.

Full MRK Calculator →
📬

Get this RIBS vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RIBS vs SCHDRIBS vs JEPIRIBS vs ORIBS vs KORIBS vs MAINRIBS vs JNJRIBS vs ABBVRIBS vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.